Mumbai, July 25 -- Profit before tax (PBT) stood at Rs 1,769.93 crore in Q1 FY26, marking an 9.84% increase from Rs 1,611.36 crore reported in the same quarter last year.
EBITDA rose 3.6% to Rs 1,778 crore in Q1 FY26, as against Rs 1,716 crore reported in Q1 FY25. The EBITDA margin remained stable at 25.6%.
The company's One India Business delivered a growth of 6% YoY for the quarter, breaching the threshold of Rs 3,000 crore for the first time ever in the opening quarter of any financial year.
In North America, Cipla reported quarterly revenue of $226 million, driven by strong traction in differentiated assets. Key launches during the quarter included Nano Paclitaxel vials (ANDA) and Nilotinib Capsules (NDA).
The One Africa region co...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.